A Phase III trial linking morning administration of immunochemotherapy to dramatically better surviv...
Nature Medicine Retracts Viral Lung Cancer Timing Study After Four-Month Investigation
A Phase III trial linking morning administration of immunochemotherapy to dramatically better survival outcomes in non-small cell lung cancer has been...
Author: Applied Clinical Trials Online
Read Original Article